Steven E. Lipshultz
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Emergency Medicine top 0.05%
- HIV-related health complications and treatments
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 100
- Cardiomyopathy and Myosin Studies 51
- Cardiovascular Function and Risk Factors 24
- Viral Infections and Immunology Research 24
-
- HIV-related health complications and treatments 68
- Co-authors
- Steven D. Colan (119 shared papers)Stephen E. Sallan (37 shared papers)Tracie L. Miller (84 shared papers)Stuart R. Lipsitz (43 shared papers)E. John Orav (41 shared papers)Richard D. Gelber (12 shared papers)Stephen P. Sanders (11 shared papers)Jeffrey A. Towbin (51 shared papers)
- Journals
- Journal of Clinical Oncology (30 papers)Circulation (30 papers)Journal of the American College of Cardiology (20 papers)American Heart Journal (15 papers)PEDIATRICS (13 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Steven E. Lipshultz
382 papers receiving 22.7k citations
Steven E. Lipshultz's Hit Papers
Peers
Comparison fields: 5 of 187
- Cardiology and Cardiovascular Medicine 12.7k
- Emergency Medicine 1.9k
- Pediatrics, Perinatology and Child Health 3.6k
- Oncology 2.7k
- Virology 446
Countries citing papers authored by Steven E. Lipshultz
This map shows the geographic impact of Steven E. Lipshultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Lipshultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Lipshultz more than expected).
Fields of papers citing papers by Steven E. Lipshultz
This network shows the impact of papers produced by Steven E. Lipshultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Lipshultz. The network helps show where Steven E. Lipshultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven E. Lipshultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 388 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood Hit paper breakdown → | 1991 | 1049 |
| 2 | Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in Children Hit paper breakdown → | 2006 | 665 |
| 3 | Health Effects of Energy Drinks on Children, Adolescents, and Young Adults Hit paper breakdown → | 2011 | 645 |
| 4 | Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer Hit paper breakdown → | 1995 | 586 |
| 5 | The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States Hit paper breakdown → | 2003 | 557 |
| 6 | Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia Hit paper breakdown → | 2005 | 514 |
| 7 | Dilated cardiomyopathy Hit paper breakdown → | 2019 | 434 |
| 8 | 2004 | 424 | |
| 9 | Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions Hit paper breakdown → | 2013 | 398 |
| 10 | 2008 | 369 | |
| 11 | 1997 | 366 | |
| 12 | The Safety of Ingested Caffeine: A Comprehensive Review Hit paper breakdown → | 2017 | 366 |
| 13 | 2004 | 349 | |
| 14 | 2002 | 349 | |
| 15 | 2005 | 325 | |
| 16 | 2010 | 320 | |
| 17 | 2006 | 311 | |
| 18 | 1997 | 310 | |
| 19 | 2008 | 286 | |
| 20 | 2007 | 280 |
About Steven E. Lipshultz
Steven E. Lipshultz is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine, Pediatrics, Perinatology and Child Health, Surgery and Epidemiology, having authored 388 papers that have together received 23.3k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (100 papers), HIV-related health complications and treatments (68 papers), Cardiomyopathy and Myosin Studies (51 papers), Childhood Cancer Survivors' Quality of Life (47 papers), Congenital Heart Disease Studies (29 papers), Cardiovascular Function and Risk Factors (24 papers), Viral Infections and Immunology Research (24 papers) and Acute Lymphoblastic Leukemia research (20 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (12.7k citations), Emergency Medicine (1.9k citations), Pediatrics, Perinatology and Child Health (3.6k citations), Oncology (2.7k citations) and Virology (446 citations). Steven E. Lipshultz has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Steven D. Colan, Stephen E. Sallan, Tracie L. Miller, Stuart R. Lipsitz, E. John Orav, Richard D. Gelber, Stephen P. Sanders, Jeffrey A. Towbin, M. Jacob Adams and Vivian I. Franco. Their work appears in journals such as Journal of Clinical Oncology, Circulation, Journal of the American College of Cardiology, American Heart Journal and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.